Induced Abortion
Conditions
Interventions
Sufentanil Group:Sufentanil (0.1 µg/kg) combined with ciprofol (0.4 mg/kg).
Oliceridine Group:Oliceridine (20 µg/kg) combined with ciprofol (0.4 mg/kg).
Sponsors
Shaanxi Nuclear Industry No. 215 Hospital
Eligibility
Sex/Gender
Female
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: 1. Women; 2. 18-50 years old; 3. Patients undergoing elective painless induced abortion; 4.ASA grade I-III; 5.BMI 18.5-29.9 kg/m^2;
Exclusion criteria
Exclusion criteria: 1. Patients with a history of serious heart, brain, lung, liver, kidney, endocrine and psychiatric diseases; 2. The history of acute respiratory infection without cure within 14 days and obvious difficult airway; 3. Patients with known allergies to cyclopropofol, oxalidine and their components; 4. Alcoholism, long-term use of psychotropic drugs, sedative or analgesic drugs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| QoR-15 scores at 24 hours postoperatively in the oliceridine and sufentanil groups; | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient satisfaction;Hemodynamic Parameters;Induction dose and total dose of ciprofol, and dosage of vasoactive agents.;Operative time, emergence time, and discharge time.;NRS scores at emergence and upon discharge.;Intraoperative adverse events.;Adverse events in the PACU.; | — |
Countries
China
Contacts
Public ContactLiuqin Jiang
Shaanxi Nuclear Industry No. 215 Hospital
Outcome results
None listed